POLB vs. ETX, FUM, SBTX, COS, TRX, C4XD, DDDD, OKYO, AREC, and SAR
Should you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include e-therapeutics (ETX), Futura Medical (FUM), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), Tissue Regenix Group (TRX), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), Arecor Therapeutics (AREC), and Sareum (SAR). These companies are all part of the "biotechnology" industry.
Poolbeg Pharma vs. Its Competitors
Poolbeg Pharma (LON:POLB) and e-therapeutics (LON:ETX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.
Poolbeg Pharma's return on equity of -32.56% beat e-therapeutics' return on equity.
In the previous week, Poolbeg Pharma's average media sentiment score of 0.00 equaled e-therapeutics'average media sentiment score.
Poolbeg Pharma has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500. Comparatively, e-therapeutics has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.
1.2% of Poolbeg Pharma shares are owned by institutional investors. Comparatively, 26.5% of e-therapeutics shares are owned by institutional investors. 24.7% of Poolbeg Pharma shares are owned by company insiders. Comparatively, 59.4% of e-therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
e-therapeutics has higher revenue and earnings than Poolbeg Pharma. Poolbeg Pharma is trading at a lower price-to-earnings ratio than e-therapeutics, indicating that it is currently the more affordable of the two stocks.
Summary
e-therapeutics beats Poolbeg Pharma on 5 of the 9 factors compared between the two stocks.
Get Poolbeg Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Poolbeg Pharma Competitors List
Related Companies and Tools
This page (LON:POLB) was last updated on 8/2/2025 by MarketBeat.com Staff
